Even with the recent advances in pharma, the industry is still mired in very slow drug discovery cycles. The billions of dollars and well over a dozen years it takes to bring a drug to market is just the beginning. After FDA approval, a drug manufacturer must still prove the value of its drug to patients, providers, and payers.
Fortunately, there’s help. We can now accelerate the discovery and development of new drugs with future-ready, agile data technology that shortens development cycles.
MarkLogic customers have discovered an efficient approach to R&D platform development that enables:
And, you can avoid buying or managing any infrastructure by deploying these powerful, enterprise capabilities as a cloud-based managed service.
AbbVie brings drugs to market faster with a cloud-based R&D platform built on MarkLogic. Phil Hajduk, VP of R&D Information Research, explains how AbbVie can now discover data in a fraction of the time required by its previous system.